Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
Coforge, in partnership with Espero, has achieved a significant milestone in advancing digital health and clinical research. The Espero Insight Driven Protocol (IDP) solution has been honored with the “Clinical Trial Innovation Award” at the 9th Annual MedTech Breakthrough Awards, recognizing transformative contributions to the medical technology landscape.
Presented by MedTech Breakthrough, an independent market intelligence organization, the awards program celebrates the most innovative companies, solutions, and technologies across the global digital health, medical device, and diagnostics ecosystem. With thousands of nominations worldwide, this recognition underscores the impact of Coforge and Espero’s shared commitment to revolutionizing how clinical trials are designed, managed, and delivered.
The award-winning Insight Driven Protocol (IDP) platform is designed to simplify and accelerate protocol development by leveraging intelligent automation, domain expertise, and real-world evidence. It empowers life sciences organizations to reduce complexity, enhance trial design, improve patient engagement, and accelerate time-to-market—critical goals in today’s fast-evolving healthcare environment.
Coforge, in collaboration with Espero Health, has enhanced the ESPERO Insight Driven Protocol (IDP) solution, an innovative, cloud-native enterprise SaaS platform that reimagines clinical trial protocol development. Designed to enhance protocol creation, collaboration and effectiveness as well as streamline operations, ESPERO IDP leverages low-code configurability, a robust digital rules engine, and AI to accelerate protocol design. By harnessing data-driven insights, the platform enables the creation of digitized clinical protocols and seamlessly delivers them to downstream systems, including electronic case report form (eCRF) platforms.
The breakthrough solution incorporates real-time feedback from sites and patient advocacy groups to optimize protocols for success. With dynamic document generation, users can easily generate essential study documents like Statistical Analysis Plans and Informed Consent forms. ESPERO IDP also enables accurate forecasting of study costs during protocol design, streamlining feasibility and trial planning.
Using just a few keywords, ESPERO's machine learning and advanced analytics analyze hundreds of historical clinical trials and curate insights and recommendations for a study. Leveraging the latest in Generative-AI, ESPERO helps teams reduce protocol design time by 30%.
The MedTech Breakthrough Awards program celebrates excellence and innovation in health and medical technology industry, recognizing the companies, products, and solutions driving meaningful progress and improving patient care. The awards highlight the groundbreaking work transforming the healthcare landscape by spanning various categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and beyond.
This year’s program saw a record-breaking number of nominations from leading companies and startups across more than 18 countries, showcasing the global impact and momentum of the digital healthcare industry today.
About ESPERO
Espero is leading the way in modernizing clinical trials by introducing eProtocol technology to improve protocol development and simplify trial operations. Espero helps Study Sponsors and CROs digitize protocols and automate essential processes, making clinical trials faster, more efficient, and reliable. By reducing protocol development timelines by 30% and eCRF build times by 67 days, Espero helps pharmaceutical companies bring new therapies to patients sooner while upholding the highest standards of compliance and operational quality. Trusted by leading pharma companies, Espero is transforming clinical research with a commitment to efficiency, precision, and impactful technology.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provides a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
